Zusammenfassung
Auf Intensivstationen zu behandelnde Schwangere stellen eine besondere Risikogruppe dar, da hier grundsätzlich sowohl den medizinischen Bedürfnissen der Mutter als auch des in utero befindlichen Kindes Rechnung getragen werden muss. Daher gilt hier der Fokus Schwangeren, bei denen die besonderen Veränderungen des maternalen Organismus in der Schwangerschaft, der Einfluss des Kindes auf die Mutter sowie Sicherheitsbedenken für Mutter und Kind in einer potenziell lebensbedrohlichen Situation zu berücksichtigen sind. Die Diagnostik in der Schwangerschaft berücksichtigt zunächst die Bestimmung des Gestationsalters des Embryos/Fetus und ggf. Management der Frühgeburtlichkeit. Physiologische Besonderheiten wie erhöhtes thromboembolische Risiko, Strahlenschutz und Spezifika einer ggf. notwendigen medikamentösen Therapie bzw. deren Toxizität für das ungeborene Kind sind ebenso thematisiert wie spezielle peri- und postpartale Krankheitsbilder.
Similar content being viewed by others
Literatur
Al-Aqeedi RF, Al-Nabti AD (2008) Drug-eluting stent implantation for acute myocardial infarction during pregnancy with use of glycoprotein IIb/IIIa inhibitor, aspirin and clopidogrel. J Invasive Cardiol 20:E146–E149
Albarzanchi AM, Sayes CM, Ridha Albarzanchi MT, Fajt VR, Dees WL, Kraemer DC (2012) Cilostazol blocks pregnancy in naturally cycling mice. Contraception 87(4):443–448. doi:10.1016/j.contraception.2012.09.008, pii: S0010-7824(12)00818-9
Bar-Oz B, Bulkowstein M, Benyamini L, Greenberg R, Soriano I, Zimmerman D, Bortnik O, Berkovitch M (2003) Use of antibiotic and analgesic drugs during lactation. Drug Saf 26:925–935
Bates SM, Weitz JI (2003) Emerging anticoagulant drugs. Arterioscler Thromb Vasc Biol 23:1491–1500
Bates S, Greer IA, Middeldorp S, Vennstra DL, Prabulos AM, Vandvik PO (2012) VTE, thrombophilia, antithrombotic therapy, and pregnancy. Antithrombotic therapy and prevention of thrombosis. 9th ed American College of Chest Physicians. Evidence-based clinical practice guidelines. Chest 142:e691S–e736S
Bauer ME, Bauer ST, Rabbani AB, Mhyre JM (2012) Peripartum management of dual antiplatelet therapy and neuraxial labor analgesia after bare metal stent insertion for acute myocardial infarction. Anesth Analg 115:613–615
Bauersachs RM, Dudenhausen J, Faridi A, Fischer T, Fung S, Geisen U, Harenberg J, Herchenhan E, Keller F, Kemkes-Matthes B, Schinzel H, Spannagl M, Thaler CJ (2007) Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women. Thromb Haemost 98:1237–1245
Bhatt DL, Topol EJ (2000) Antiplatelet and anticoagulant therapy in the secondary prevention of ischemic heart disease. Med Clin North Am 84:163–179
Bohlmann MK (2010) Thrombophilie und Antikoagulation in der Schwangerschaft. Gynacol Geburtsmed Gynacol Endokrinol 6:30–42
Bohlmann MK, Luedders DW, Baumann K, Thill M, Hornemann A (2009) Indikationen zur Antikoagulation in der Schwangerschaft. Geburtsh Frauenheilk 69:730–732
Boztosun B, Olcay A, Avci A, Kirma C (2008) Treatment of acute myocardial infarction in pregnancy with coronary artery balloon angioplasty and stenting: use of tirofiban and clopidogrel. Int J Cardiol 127:413–416
Burdan F, Szumilo J, Dudka J, Korobowicz A, Klepacz R (2006) Congenital ventricular septal defects and prenatal exposure to cyclooxygenase inhibitors. Braz J Med Biol Res 39:925–934
Chapman ML, Martinez-Borges AR, Mertz HL (2008) Lepirudin for treatment of acute thrombosis during pregnancy. Obstet Gynecol 112:432–433
De Santis M, De Luca C, Mappa I, Cesari E, Mazza A, Quattrocchi T, Caruso A (2011) Clopidogrel treatment during pregnancy: a case report and a review of literature. Intern Med 50:1769–1773
Dempfle CE (2004) Minor transplacental passage of fondaparinux in vivo. N Engl J Med 350:1914–1915
Deutsche Gesellschaft für Gynäkologie und Geburtshilfe – DGGG (2008) Anwendung des CTG während Schwangerschaft und Geburt www.dggg.de/fileadmin/public_docs/Dokumente/Leitlinien/3–4-2_ctg_schwangerschaft_geburt_2009.pdf http://www.awmf.org/uploads/tx_szleitlinien/015-069_S1_Antenatale_Kortikosteroide_zur_Lungenreifung__ACS__07-2009_07-2014.pdf. Zugegriffen in Feb 2014
Deutsche Gesellschaft für Gynäkologie und Geburtshilfe – DGGG (2009) Antenatale Kortikosteroide zur Lungenreifung (ACS) http://www.awmf.org/uploads/tx_szleitlinien/015-069_S1_Antenatale_Kortikosteroide_zur_Lungenreifung__ACS__07-2009_07-2014.pdf. Zugegriffen in Feb 2014
Deutsche Gesellschaft für Gynäkologie und Geburtshilfe – DGGG (2010) S3-Leitlinie Prophylaxe der venösen Thromboembolie (VTE). http://www.awmf.org/uploads/tx_szleitlinien/003-001l_S3_Thromboembolie-Prophylaxe_2010_01.pdf. Zugegriffen in Feb 2014
Deutsche Gesellschaft für Gynäkologie und Geburtshilfe – DGGG (2011a) HIV-Therapie in der Schwangerschaft und bei HIV-exponierten Neugeborenen. (AWMF-Leitlinie; abgelaufen)
Deutsche Gesellschaft für Gynäkologie und Geburtshilfe – DGGG (2011b) Leitlinie: Empfehlungen für die strukturellen Voraussetzungen der perinatologischen Versorgung in Deutschland www.dggg.de/fileadmin/public_docs/Dokumente/Leitlinien/g_03_05_01_empfehlungen_strukturellen_perinatolog-ischen.pdf. Zugegriffen in Feb 2014
Deutsche Gesellschaft für Gynäkologie und Geburtshilfe – DGGG (2013) Off-Label-Use in Gynäkologie und Geburtshilfe http://www.awmf.org/uploads/tx_szleitlinien/015-057l_S1_Off-Label-Use_in_Gynäkologie_und_Geburtshilfe_2013-03.pdf. Zugegriffen in Feb 2014
Dupont C, Touzet S, Colin C, Deneux-Tharaux C, Rabilloud M, Clement HJ, Lansac J, Colle MH, Rudigoz RC (2009) Incidence and management of postpartum haemorrhage following the dissemination of guidelines in a network of 16 maternity units in France. Int J Obstet Anesth 18:320–327
El-Deeb M, El-Menyar A, Gehani A, Sulaiman K (2011) Acute coronary syndrome in pregnant women. Expert Rev Cardiovasc Ther 9:505–515
Fachinformation Abciximab. Janssen Lilly, Stand Juni 2012
Fachinformation Aggrenox. Boehringer Ingelheim, Stand Februar 2012
Fachinformation Apixaban. Bristol-Myers Squibb & Pfizer Pharma, Stand Mai 2011
Fachinformation Bivalirudin. The Medicines Company, Stand Februar 2012
Fachinformation Cilostazol. Otsuka Phrameuceutical Europe, Stand Dezember 2010
Fachinformation Clopidogrel. Sanofi, Stand April 2012
Fachinformation Dabigatran. Boehringer Ingelheim, Stand August 2012
Fachinformation Danaparoid. MSD, Stand August 2012
Fachinformation Eptifibatid. Glaxo Smith Kline, Stand März 2012
Fachinformation Lepirudin. Celgene, Stand August 2011
Fachinformation Rivaroxaban. Bayer Schering Pharma AG, Stand Dezember 2011
Fachinformation Ticagrelor. Astra Zeneca, Stand Oktober 2011
Fachinformation Tirofiban. Iroko Cardio, Stand Oktober 2010
Foxman B (2002) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 113(Suppl 1A):5S–13S
Furlan A, Vianello F, Clementi M, Prandoni P (2006) Heparin- induced thrombocytopenia occurring in the first trimester of pregnancy: successful treatment with lepirudin. A case report. Haematologica 91(8 Suppl):ECR40
Gatt S (2003) Pregnancy, delivery and the intensive care unit: need, outcome and management. Curr Opin Anaesthesiol 16:263–267
Gemeinsamer Bundesausschuss (2009) Richtlinien des Bundesausschusses der Ärzte und Krankenkassen über die ärztliche Betreuung während der Schwangerschaft und nach der Entbindung („Mutterschafts-Richtlinien“) www.g-ba.de/downloads/62–492–358/RL_Mutter-2009–06–18.pdf. Zugegriffen in Feb 2014
Hajj-Chahine J, Jayle C, Tomasi J, Corbi P (2010) Successful surgical management of massive pulmonary embolism during the second trimester in a parturient with heparin-induced thrombocytopenia. Interact Cardiovasc Thorac Surg 11:679–681
Hazelgrove JF, Price C, Pappachan VJ, Smith GB (2001) Multicenter study of obstetric admissions to 14 intensive care units in southern England. Crit Care Med 29:770–775
Hernandez RK, Werler MM, Romitti P, Sun L, Anderka M (2012) Nonsteroidal antiinflammatory drug use among women and the risk of birth defects. Am J Obstet Gynecol 206:228.e1–228.e8
Karsten J, Bohlmann MK, Sedemund-Adib B, Wnent J, Paarmann H, Iblher P, Meier T, Heinze H (2012) Electrical impedance tomography may optimize ventilation in a postpartum woman with respiratory failure. Int J Obstet Anesth. doi:10.1016/j.ijoa.2012.09.002, pii: S0959-289X(12)00123-9
Kealey A (2010) Coronary artery disease and myocardial infarction in pregnancy: a review of epidemiology, diagnosis, and medical and surgical management. Can J Cardiol 26:185–189
Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF (2006) WHO analysis of causes of maternal death: a systematic review. Lancet 367:1066–1074
Knight M, Berg C, Brocklehurst P, Kramer M, Lewis G, Oats J, Roberts CL, Spong C, Sullivan E, van Roosmalen J, Zwart J (2012) Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations. BMC Pregnancy Childbirth 12:7
Kozer E, Nikfar S, Costei A, Boskovic R, Nulman I, Koren G (2002) Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol 187:1623–1630
Lapinsky SE, Posadas-Calleja JG, McCullagh I (2009) Clinical review: ventilatory strategies for obstetric, brain-injured and obese patients. Crit Care 13:206
Lucas DN, Robinson PN, Nel MR (2012) Sepsis in obstetrics and the role of the anaesthetist. Int J Obstet Anesth 21:56–67
Magnani HN (2010) An analysis of clinical outcomes of 91 pregnancies in 83 women treated with danaparoid (Orgaran). Thromb Res 125:297–302
Markestad T, Kaaresen PI, Ronnestad A, Reigstad H, Lossius K, Medbo S, Zanussi G, Engelund IE, Skjaerven R, Irgens LM, Norwegian Extreme Prematurity Study Group (2005) Early death, morbidity, and need of treatment among extremely premature infants. Pediatrics 115:1289–1298
Millar LK, Cox SM (1997) Urinary tract infections complicating pregnancy. Infect Dis Clin North Am 11:13–26
Patel SJ, Reede DL, Katz DS, Subramaniam R, Amorosa JK (2007) Imaging the pregnant patient for nonobstetric conditions: algorithms and radiation dose considerations. Radiographics 27:1705–1722
Pettiti D, Sidney S, Quesenberry CP, Bernstein A (1997) Incidence of stroke and myocardial infarction in women of reproductive age. Stroke 28:280–283
Rath W, Hackethal A, Bohlmann MK (2012) Second-line treatment of postpartum haemorrhage (PPH). Arch Gynecol Obstet 286:549–561
RCOG (2009) Green – top Guideline No. 52: prevention and management of post partum haemorrhage. RCOG, London
Salomon J, Schnitzler A, Ville Y, Laffont I, Perronne C, Denys P, Bernard L (2009) Prevention of urinary tract infection in six spinal cord-injured pregnant women who gave birth to seven children under a weekly oral cyclic antibiotic program. Int J Infect Dis 13:399–402
Santiago-Diaz P, Arrebola-Moreno AL, Ramirez-Hernandez JA, Melgares-Moreno R (2009) Platelet antiaggregants in pregnancy. Rev Esp Cardiol 62:1193–1205
Schaefer C, Spielmann H, Vetter K (2006) Arzneiverordnung in Schwangerschaft und Stillzeit. 7. Aufl. Elsevier, Urban & Fischer, München
Sebastian C, Scherlag M, Kugelmass A, Schechter E (1998) Primary stent implantation for acute myocardial infarction during pregnancy: use of abciximab, ticlopidine, and aspirin. Cathet Cardiovasc Diagn 45:275–279
Tanimura K, Ebina Y, Sonoyama A, Morita H, Miyata S, Yamada H (2012) Argatroban therapy for heparin-induced thrombocytopenia during pregnancy in a woman with hereditary antithrombin deficiency. J Obstet Gynaecol Res 38:749–752
Tello-Montoliu A, Seecheran NA, Angiolillo DJ (2012) Successful pregnancy and delivery on prasugrel treatment: considerations for the use of dual antiplatelet therapy during pregnancy in clinical practice. J Thromb Thrombolysis [Epub vor Druck]
Tröger B, Härtel C, Manner D, Eckey T, Bohlmann MK (2012) Kongenitale Gerinnungsstörungen – gynäkologische und neonatologische Aspekte. Gynakologe 45:383–390
Van Bogaert LJ, Dhai A (2008) Ethical challenges of treating the critically ill pregnant patient. Best Pract Res Clin Obstet Gynaecol 22:983–996
Vasquez DN, Estenssoro E, Canales HS, Reina R, Saenz MG, Das Neves AV, Toro MA, Loudet CI (2007) Clinical characteristics and outcomes of obstetric patients requiring ICU admission. Chest 131:718–724
Wang L, He K, Maxwell B, Grossman SJ, Tremaine LM, Humphreys WG, Zhang D (2011) Tissue distribution and elimination of [14C]apixaban in rats. Drug Metab Dispos 39:256–264
WHO (2008) Managing puerpural sepsis. http://whqlibdoc.who.int/publications/2008/9789241546669_6_eng.pdf. Zugegriffen in Feb 2014
Young SK, Al-Mondhiry HA, Vaida SJ, Ambrose A, Botti JJ (2008) Successful use of arbatroban during the third trimester of pregnancy: case report and review of the literature. Pharmacotherapy 28:1531–1536
Zhao M, Chang C, Liu Z, Chen LM, Chen Q (2010) Treatment with low-dose aspirin increased the level LIF and integrin β3 expression in mice during the implantation window. Placenta 31:1101–1105
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Berlin Heidelberg
About this entry
Cite this entry
Bohlmann, M. (2015). Schwangere in der Intensivmedizin. In: Marx, G., Muhl, E., Zacharowski, K. (eds) Die Intensivmedizin. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54675-4_103-1
Download citation
DOI: https://doi.org/10.1007/978-3-642-54675-4_103-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-54675-4
eBook Packages: Springer Referenz Medizin
Publish with us
Chapter history
-
Latest
Schwangere in der Intensivmedizin- Published:
- 11 November 2022
DOI: https://doi.org/10.1007/978-3-642-54675-4_103-2
-
Original
Schwangere in der Intensivmedizin- Published:
- 29 May 2015
DOI: https://doi.org/10.1007/978-3-642-54675-4_103-1